GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imeik Technology Development Co Ltd (SZSE:300896) » Definitions » 3-Year Revenue Growth Rate

Imeik Technology Development Co (SZSE:300896) 3-Year Revenue Growth Rate : 22.20% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Imeik Technology Development Co 3-Year Revenue Growth Rate?

Imeik Technology Development Co's Revenue per Share for the three months ended in Mar. 2024 was ¥2.68.

During the past 12 months, Imeik Technology Development Co's average Revenue per Share Growth Rate was 42.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 22.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 42.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of Imeik Technology Development Co was 74.60% per year. The lowest was 22.20% per year. And the median was 49.90% per year.


Competitive Comparison of Imeik Technology Development Co's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Imeik Technology Development Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imeik Technology Development Co's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imeik Technology Development Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Imeik Technology Development Co's 3-Year Revenue Growth Rate falls into.



Imeik Technology Development Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Imeik Technology Development Co  (SZSE:300896) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Imeik Technology Development Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Imeik Technology Development Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Imeik Technology Development Co (SZSE:300896) Business Description

Traded in Other Exchanges
N/A
Address
No. Jia 92 Jianguo Road, 21st, Block C, Shimao Building, Chaoyang District, Beijing, CHN, 100022
Imeik Technology Development Co Ltd is a national enterprise focusing on the research and development, manufacture and sales of biomedical materials. The company's products include Medical Cosmetic Platform; General Surgery Platform; and Biological Technology Platform.

Imeik Technology Development Co (SZSE:300896) Headlines

No Headlines